The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 As per The Business Research Company’s Neurological Biomarkers Global Market Report 2023, The global neurological biomarkers market is expected to grow from $8.40 billion in 2022 to $9.46 billion in 2023 at a compound annual growth rate (CAGR) of 12.7%. The neurological biomarkers market is expected to reach $15.07 billion in 2027 at a CAGR of 12.3%.

What was the major driver in the neurological biomarkers market?
The increasing prevalence of neurological diseases is expected to propel the growth of the neurological biomarker market going forward. Neurological illnesses affect the brain, spinal cord, and all of the body’s other nerves. Parkinson’s disease is a neurodegenerative disorder affecting the neurological system and the areas of the body that are under the control of the nerves. Neurological biomarkers help provide an early diagnosis of Parkinson’s disease using pathological, biochemical, and genetic testing. For instance, in December 2022, according to the Parkinson’s Foundation, a US-based non-profit organization, the number of new diagnoses of Parkinson’s disease reached 90,000 in 2022, up from 60,000 per year in 2021. Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurological biomarker market.

View More On The Neurological Biomarkers Market Report 2023 – https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

What was the key trend in the neurological biomarkers market?
Drug development agreements are the key trend gaining popularity in the neurological biomarkers market. Major companies operating in the neurological biomarkers market are developing new drugs to sustain their position in the market. For instance, in August 2020, Johnson & Johnson Services Inc., a US-based pharmaceutical company, entered into an agreement with Enigma Biomedical Group, a Canada-based biotechnology company, for the assessment of two novel neuroimaging biomarkers including JNJ-64413739 and JNJ-64511070. These biomarkers have the potential to offer vital new tools for improving comprehension of a variety of neurological disorders, including Alzheimer’s disease and other dementias.

Which was the largest region in the neurological biomarkers market?
North America was the largest region in the neurological biomarkers market in 2022. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the neurological biomarkers market prominent players?
Major players in the neurological biomarkers market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, and Acumen Pharmaceuticals.

Key neurological biomarkers market segments
The global neurological biomarkers market is segmented –
1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Request A Sample Of The Global Neurological Biomarkers Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12677&type=smp

The Neurological Biomarkers Global Market Report 2023  provides a comprehensive overview on the neurological biomarkers market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Biomarkers Global Market Report 2023
Rare Neurological Disease Treatment Global Market Report 2023
Cardiac Biomarkers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model